Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Acadesine reduces CABG-associated mortality and morbidity

Jan. 22, 1997

New endothelin antagonists from Zeneca

Jan. 22, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Medtronic's arrhythmia management device enters clinic

Jan. 20, 1997

Terumo prepares smooth muscle cell proliferation inhibitors

Jan. 17, 1997

Sigma-Tau reports therapeutically active seco-D steroid derivatives

Jan. 17, 1997

February review for Medco's vasodilator combination

Jan. 16, 1997

Long-acting calcium channel blocker proves effective in post-MI patients

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...